Ruth O'Regan

13PUBLICATIONS
35CO-AUTHORS
Courts and sentencingCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsPopulation trends and policies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 02, 2024
Dr V. Craig Jordan, PhD, DSc, FAACR.

Debra A Tonetti, Clodia Osipo, Ruth M O'Regan

|Mar 25, 2024
Breast cancer therapy in China: Introducing the Special Collection.

Xiaojia Wang, Ruth M O'Regan

|Jun 23, 2023
A review of treatment options in HER2-low breast cancer and proposed treatment sequencing algorithm.

Arya Mariam Roy, Vasanthan Muthusamy Kumarasamy, Ajay Dhakal

|May 19, 2023
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.

Kevin Kalinsky, Melissa K Accordino, Codruta Chiuzan

|May 12, 2023
Margetuximab in HER2-positive metastatic breast cancer.

William J Gradishar, Ruth O'Regan, Mothaffar F Rimawi

|Nov 08, 2022
When the personal becomes political: The impact of the Dobbs decision on women with cancer.

Jane Lowe Meisel, Amy Harrington, Natalie Whaley

Pageof 3

Frequent Collaborators

2 joint publications

Jane Lowe Meisel

2 joint publications

Marina N Sharifi

2 joint publications

William J Gradishar

1 joint publications

Amy Harrington